DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
4.230
+0.140 (3.42%)
Jun 6, 2025, 1:49 PM - Market open
DiaMedica Therapeutics Employees
As of December 31, 2024, DiaMedica Therapeutics had 28 total employees, including 27 full-time and 1 part-time employees. The number of employees increased by 9 or 47.37% compared to the previous year.
Employees
28
Change (1Y)
9
Growth (1Y)
47.37%
Revenue / Employee
n/a
Profits / Employee
-$964,286
Market Cap
181.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
DMAC News
- 15 days ago - DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025 - Business Wire
- 18 days ago - DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia - Business Wire
- 22 days ago - DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025 - Business Wire
- 23 days ago - DiaMedica Therapeutics Inc. (DMAC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights - Business Wire
- 4 weeks ago - DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May - Business Wire
- 4 weeks ago - DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025 - Business Wire
- 2 months ago - DiaMedica Therapeutics Inc. (DMAC) Q4 2024 Earnings Call Transcript - Seeking Alpha